RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

Sam Cross-Knorr(Brown University), Devasis Chatterjee(Brown University)
BMC Cancer
October 8, 2013
Cited by 57


Related Papers